DK167559B1 - Buprenorphinholdigt farmaceutisk suppositorium - Google Patents

Buprenorphinholdigt farmaceutisk suppositorium Download PDF

Info

Publication number
DK167559B1
DK167559B1 DK305087A DK305087A DK167559B1 DK 167559 B1 DK167559 B1 DK 167559B1 DK 305087 A DK305087 A DK 305087A DK 305087 A DK305087 A DK 305087A DK 167559 B1 DK167559 B1 DK 167559B1
Authority
DK
Denmark
Prior art keywords
polyethylene glycol
suppository
buprenorphine
suppositories
propylene glycol
Prior art date
Application number
DK305087A
Other languages
Danish (da)
English (en)
Other versions
DK305087D0 (da
DK305087A (da
Inventor
Chikamasa Yamashita
Kouzo Ishida
Gohachiro Miyamoto
Muneyoshi Ishikawa
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of DK305087D0 publication Critical patent/DK305087D0/da
Publication of DK305087A publication Critical patent/DK305087A/da
Application granted granted Critical
Publication of DK167559B1 publication Critical patent/DK167559B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK305087A 1986-06-16 1987-06-16 Buprenorphinholdigt farmaceutisk suppositorium DK167559B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14108686 1986-06-16
JP61141086A JPS62298530A (ja) 1986-06-16 1986-06-16 坐薬用医薬組成物

Publications (3)

Publication Number Publication Date
DK305087D0 DK305087D0 (da) 1987-06-16
DK305087A DK305087A (da) 1987-12-17
DK167559B1 true DK167559B1 (da) 1993-11-22

Family

ID=15283879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK305087A DK167559B1 (da) 1986-06-16 1987-06-16 Buprenorphinholdigt farmaceutisk suppositorium

Country Status (10)

Country Link
US (1) US4784855A (de)
EP (1) EP0253143B1 (de)
JP (1) JPS62298530A (de)
AT (1) ATE67932T1 (de)
CA (1) CA1283605C (de)
DE (1) DE3773440D1 (de)
DK (1) DK167559B1 (de)
ES (1) ES2039377T3 (de)
IE (1) IE59668B1 (de)
PT (1) PT85086B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP2007016052A (ja) * 1998-03-03 2007-01-25 Eisai R & D Management Co Ltd 抗痴呆薬を含有した経皮適用製剤又は坐剤
WO2004054554A1 (en) * 2002-12-13 2004-07-01 Euro-Celtique S.A. Transdermal buprenorphine to treat pain in sickle cell crisis
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
BRPI0811319A2 (pt) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
WO2018165183A1 (en) * 2017-03-06 2018-09-13 Tactus Therapeutics, Inc. Abuse deterrent opioid formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
DE2229770A1 (de) * 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
US4004010A (en) * 1972-06-19 1977-01-18 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N-(furyl-methyl)-7α-acyl-6,14-(endoetheno or endoethano)-tetrahydro-nororipavine or -northebaine and method of use
DE2230154A1 (de) * 1972-06-21 1974-01-17 Boehringer Sohn Ingelheim N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
JPS54157820A (en) * 1978-05-30 1979-12-13 Res Inst For Prod Dev Preparation of multi-layered suppository base
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents

Also Published As

Publication number Publication date
IE871522L (en) 1987-12-16
US4784855A (en) 1988-11-15
DE3773440D1 (de) 1991-11-07
CA1283605C (en) 1991-04-30
EP0253143B1 (de) 1991-10-02
ES2039377T3 (es) 1993-10-01
IE59668B1 (en) 1994-03-09
PT85086B (pt) 1990-03-08
ATE67932T1 (de) 1991-10-15
EP0253143A3 (en) 1989-08-23
EP0253143A2 (de) 1988-01-20
JPH0475889B2 (de) 1992-12-02
DK305087D0 (da) 1987-06-16
JPS62298530A (ja) 1987-12-25
PT85086A (en) 1987-07-01
DK305087A (da) 1987-12-17

Similar Documents

Publication Publication Date Title
EP0319243B1 (de) Pharmazeutische Zusammensetzungen
EP0394026B1 (de) Formulierung, ein Imidazo[4,5-c]Quinolin-Derivat enthaltend
DK167559B1 (da) Buprenorphinholdigt farmaceutisk suppositorium
EP0672422B1 (de) Entzündunghemmendes und analgetisches transdermales Gel enthaltend Ketoprofen
CA1200501A (en) Nalbuphine - narcotic analgesic composition and method of producing analgesia
US4555524A (en) Transdermal 2-(4-isobutylphenyl)-propionic acid medication and methods
US4879297A (en) Fatty acids and their small chain esters as penetration enhancers in aqueous systems
AU2007292912A1 (en) Dry powder compound formulations and uses thereof
EP0375689A1 (de) Eine pharmazeutische zusammensetzung angepasst an die transdermale applikation eines opioids.
KR20010078754A (ko) 통증 경감 방법 및 통증 경감용 경피 조성물
EP0069600A2 (de) Pharmazeutische Präparate
US4879274A (en) External medication for skin
US6113937A (en) Sustained release sufentanil compositions
US6365590B1 (en) Compounds, compositions and methods for treating erectile dysfunction
JPH02326B2 (de)
RU2152215C1 (ru) Применение ропивакаина при изготовлении фармацевтического препарата с анальгезирующим действием с минимальной моторной блокадой
EP0027991A1 (de) Verwendung eines Gemisches von Verbindungen zur Linderung von Schmerzen
EP0380047A2 (de) Perkutan- oder schleimhautdurchdringender Absorptionsbeschleuniger und Perkutan- oder schleimhautdurchdringendes Arzneimittel
KR890014109A (ko) 의약제
EP0728479A1 (de) Deacetylmoxisylyte in der Behandlung von akuter Harnzurückhaltung
EP0005074A1 (de) Stoff und Zusammensetzung zur Senkung des Blutdruckes
CA2243657C (en) Compositions for treatment of erectile dysfunction
EP0365134A1 (de) Synergetische Zusammensetzung eines dopaminergischen Agens und Angiotensin-Umwandlungsenzym-Inhibitoren
JP3679141B2 (ja) ダナゾール含有皮膚外用剤組成物
KR100215194B1 (ko) 근육 투여용 니메술라이드 함유 주사용 진통제 조성물

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK